Aptose Announces Appointment of Carol Ashe to Board of Directors
(World News Science)

SAN DIEGO and TORONTO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced the appointment of Ms. Carol Ashe to the Board of Directors effective immediately. Aptose`s Board of Directors now includes seven members with extensive experience across diverse disciplines in biotechnology, pharmaceutical development and financial experience. Ms. Ashe is an accomplished executive leader with more than 25 years of experience in corporate, legal, business development and...